Drug Trial Radar · NCT06472232
Multicenter Study of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia
Last checked: Nov 20, 2026Latest source record: Jun 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
356
Planned (sponsor's estimate)
Start
Jun 18, 2024
Primary completion
Jun 16, 2025
Study completion Sep 30, 2025
Sponsor
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beijing Obstetrics and Gynecology Hospital; International Peace Maternity and Child Health Hospital; Nanjing Medical University; Anhui Women and Children's Medical Center; Jiaxing Maternity and Child Health Care Hospital; Gansu Maternal and Child Health Center; Urumqi Maternal and Child Health Center; Shengjing Hospital; Zhongnan Hospital; Second Affiliated Hospital of Wenzhou Medical University; Second Hospital of Jilin University
- First posted
- Jun 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Women requiring epidural labor analgesia were randomized into two groups, one with the local anesthetic chloroprocaine and the other with ropivacaine. The primary outcome was to observe the analgesic scores of the two groups of drugs as well as adverse reactions.
Conditions
- Obstetric Labor
Interventions
ChloroprocaineDrug
Selection of low concentration of chloroprocaine as local anesthetic for labor analgesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of effective analgesiaTime frame: 30 min after the first epidural addition at the beginning of labor analgesia
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.